UltraNav-enabled therapy

About Delsona Therapeutics

Delsona Therapeutics is a private, clinical-stage company founded in 2021 and based in Cambridge, Massachusetts. It is developing the UltraNav platform, an ultrasound-based technology designed to overcome the significant challenge of the blood-brain barrier for drug delivery to the CNS. With a drug-agnostic approach, Delsona has initiated human trials in pediatric brain cancer and Alzheimer's disease, leveraging the strong scientific foundation of its founder, Dr. Elisa Konofagou. The company represents a convergence of biomedical engineering and therapeutics aimed at unlocking new treatments for neurological disorders.

About Delsona Therapeutics

Delsona Therapeutics is a private, clinical-stage company founded in 2021 and based in Cambridge, Massachusetts. It is developing the UltraNav platform, an ultrasound-based technology designed to overcome the significant challenge of the blood-brain barrier for drug delivery to the CNS. With a drug-agnostic approach, Delsona has initiated human trials in pediatric brain cancer and Alzheimer's disease, leveraging the strong scientific foundation of its founder, Dr. Elisa Konofagou. The company represents a convergence of biomedical engineering and therapeutics aimed at unlocking new treatments for neurological disorders.

Therapeutic Areas